← Back to Search

Behavioural Intervention

Suicide Prevention Interventions for Suicide Prevention (SPARC Trial)

N/A
Waitlist Available
Led By Anna K Radin, DrPH, MPH
Research Sponsored by St. Luke's Health System, Boise, Idaho
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
12-17 years old (adolescents) or 18+ years old (adults)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

SPARC Trial Summary

This trial will compare the effectiveness of two brief suicide prevention interventions in reducing suicidal ideation and behavior, and increasing uptake of outpatient mental healthcare services, over 12 months.

Who is the study for?
This trial is for adolescents (12-17) and adults (18+) who have shown signs of suicide risk or attempted suicide, are patients at St. Luke's Health System ED or Primary Care Clinic, can use a phone and email, and speak English or Spanish. Those unable to consent or deemed unsuitable by a provider cannot join.Check my eligibility
What is being tested?
The study tests two brief interventions for preventing suicide: SPI+ involves safety planning plus follow-up calls from a hotline; SP+CC includes safety planning with caring contacts. Their effectiveness in reducing suicidal thoughts/behaviors and loneliness will be compared over 12 months.See study design
What are the potential side effects?
While not typical side effects as seen with medications, participants may experience emotional discomfort discussing sensitive topics like suicidality during the interventions.

SPARC Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am at least 12 years old.

SPARC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Attendance at Outpatient Behavioral Health Appointments
Loneliness; measured using the NIH Toolbox Emotion Batteries Loneliness Scale
Suicidal Ideation & Behavior; measured using the Columbia Suicide Severity Rating Scale (C-SSRS) since-last-contact screener (self-assessment)
+1 more

SPARC Trial Design

2Treatment groups
Experimental Treatment
Group I: SPI+: Safety Planning Intervention plus structured phone-based follow-upExperimental Treatment1 Intervention
The Safety Planning Intervention (SPI+) includes safety planning (moderate or high risk for suicide) or connection & support planning (low risk for suicide) at the clinic or ED, plus a structured telephone-based intervention from a suicide prevention hotline
Group II: Caring Contacts: Safety Planning Intervention plus Caring Contacts (SP+CC)Experimental Treatment1 Intervention
SP+CC will include safety planning (moderate or high risk for suicide) or connection & support planning (low risk for suicide) at the clinic or ED, plus caring text messages or emails from a suicide prevention hotline.

Find a Location

Who is running the clinical trial?

St. Luke's Health System, Boise, IdahoLead Sponsor
3 Previous Clinical Trials
1,515 Total Patients Enrolled
1 Trials studying Suicide
849 Patients Enrolled for Suicide
Patient-Centered Outcomes Research InstituteOTHER
550 Previous Clinical Trials
29,995,428 Total Patients Enrolled
6 Trials studying Suicide
5,210 Patients Enrolled for Suicide
Idaho Suicide Prevention Hotline (Jannus, Inc.)UNKNOWN
1 Previous Clinical Trials
666 Total Patients Enrolled

Media Library

SP+CC (Caring Contacts) (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04893447 — N/A
Suicide Research Study Groups: Caring Contacts: Safety Planning Intervention plus Caring Contacts (SP+CC), SPI+: Safety Planning Intervention plus structured phone-based follow-up
Suicide Clinical Trial 2023: SP+CC (Caring Contacts) Highlights & Side Effects. Trial Name: NCT04893447 — N/A
SP+CC (Caring Contacts) (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04893447 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are currently participating in this experiment?

"Affirmative. The details posted on clinicaltrials.gov verify that this medical trial is currently recruiting participants, with 1382 required from a single site since its May 20th 2021 debut date and last update of November 3rd 2022."

Answered by AI

Is there an ongoing enrollment period for this clinical research?

"The data provided on clinicaltrials.gov implies that this trial is still acccepting participants, with the original post date being May 20th 2021 and its last update occuring on November 3rd 2022."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Suicide Prevention Among Recipients of Care
Anna Radin 2021. "Suicide Prevention Among Recipients of Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04893447.
~82 spots leftby Jul 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top